Biotech ETFs are movin’ on up on news that Pfizer is buying Array BioPharma for over $10 billion. SPDR S&P Biotech (XBI), iShares Nasdaq Biotechnology ETF (IBB), and ALPS Medical Breakthroughs ETF (SBIO) rose with the announcement of the acquisition. ETFs like XBI and IBB have fundamental...